The global 3D printed drugs market size was USD 310.80 million in 2023, calculated at USD 338.28 million in 2024 and is expected to reach around USD 789.20 million by 2034, expanding at a CAGR of 8.84% from 2024 to 2034. The North America 3D printed drugs market size reached USD 118.10 million in 2023. The benefits of 3D printed drugs include helping to get novel medicines to patients rapidly. 3D printing is beneficial for patients with rarer conditions, for making bespoke pills with precise dosages, and for delivering personalized medicines to patients’ needs. These factors help to the growth of the market.
The global surgical robot accessories market size was USD 5.32 billion in 2023, calculated at USD 5.80 billion in 2024 and is expected to reach around USD 13.78 billion by 2034. The market is expanding at a solid CAGR of 9.03% over the forecast period 2024 to 2034. The robust growth in healthcare infrastructure to boost the expansion of the market in the coming years.
The global healthcare workforce management system market size was USD 2.10 billion in 2023, calculated at USD 2.28 billion in 2024 and is expected to reach around USD 5.20 billion by 2034, expanding at a CAGR of 8.59% from 2024 to 2034. The healthcare workforce management system market is expected to grow significantly, driven by the shift toward value-based reimbursements and the increasing adoption of telehealth technologies.
The global teledentistry market size was USD 1.52 billion in 2023, calculated at USD 1.75 billion in 2024 and is expected to reach around USD 7.18 billion by 2034. The market is expanding at a solid CAGR of 15.15% over the forecast period 2024 to 2034. The North America teledentistry market size reached USD 550 million in 2023. Teledentistry benefits include reduced fear factors, such as patients experiencing less anxiety because of convenience and reduced need for travel, improved accessibility, such as remote care and communication, making dentistry more accessible, lower costs while still providing quality care, and more precise treatment. These factors help to the growth of the market.
The global psoriatic arthritis treatment market size was USD 11.30 billion in 2023, calculated at USD 12.18 billion in 2024 and is expected to reach around USD 25.89 billion by 2034, expanding at a CAGR of 7.83% from 2024 to 2034. The North America psoriatic arthritis treatment market size reached USD 4.75 billion in 2023. Rising the prevalence of psoriatic arthritis diseases can boost the psoriatic arthritis treatment market.
The global retail clinics market size was USD 5.10 billion in 2023, calculated at USD 5.51 billion in 2024 and is expected to reach around USD 12.04 billion by 2034, expanding at a CAGR of 8.12% from 2024 to 2034. The retail clinics market is growing due to the rising demand for convenient and accessible healthcare services in retail settings.
The global oral transmucosal drugs market size was USD 34.41 billion in 2023, calculated at USD 36.72 billion in 2024 and is expected to reach around USD 70.37 billion by 2034, expanding at a CAGR of 6.72% from 2024 to 2034. The North America oral transmucosal drugs market size reached USD 13.76 billion in 2023. The growth of the oral transmucosal drugs market is attributed to the increasing demand for efficient and rapid drug delivery systems, particularly for medications that require swift absorption into the bloodstream.
The global burn care centers market size was USD 24.08 billion in 2023, calculated at USD 25.10 billion in 2024 and is expected to reach around USD 37.94 billion by 2034, expanding at a CAGR of 4.22% from 2024 to 2034. The North America burn care centers market size reached USD 10.84 billion in 2023. The increasing incidence of trauma cases globally and the hospitalizations related to these are the primary drivers for the burn care centers market.
The global inflammatory bowel disease treatment market size was USD 20.77 billion in 2023, calculated at USD 31.34 billion in 2024 and is expected to reach around USD 31.34 billion by 2034, expanding at a CAGR of 3.81% from 2024 to 2034. The North America inflammatory bowel disease treatment market size was valued at USD 12.25 billion in 2023. The rising prevalence of ulcerative colitis and Crohn's disease across the globe and increasing approval of novel therapeutics are anticipated to drive the inflammatory bowel disease treatment market.
The global dental charting software market size was USD 1.42 billion in 2023, calculated at USD 1.60 billion in 2024 and is expected to reach around USD 5.14 billion by 2034. The market is expanding at a solid CAGR of 12.41% over the forecast period 2024 to 2034. The North America dental charting software market size reached USD 510 million in 2023. The increasing oral health awareness among individuals is fueling the market growth.
The global locum tenens staffing market size was USD 8.83 billion in 2023, calculated at USD 9.5 billion in 2024 and is expected to reach around USD 19.74 billion by 2034, expanding at a CAGR of 7.59% from 2024 to 2034. The North America locum tenens staffing market size reached USD 4.68 billion in 2023. The shortage of healthcare professionals compared to healthcare facilities is driving the growth of the market.
The global respiratory disorders treatment market size was USD 107.50 billion in 2023, calculated at USD 114.05 billion in 2024 and is expected to reach around USD 206.19 billion by 2034, expanding at a CAGR of 6.10% from 2024 to 2034. The rising emphasis on personalized medicine is observed to support the overall expansion of the market.
The global infectious disease molecular diagnostics market size was USD 44.58 billion in 2023, calculated at USD 46.03 billion in 2024 and is expected to reach around USD 63.37 billion by 2034, expanding at a CAGR of 3.25% from 2024 to 2034. The North America infectious disease molecular diagnostics market size reached USD 17.39 billion in 2023. It helps in the identification and detection of infectious agents like parasites, fungi, bacteria, and viruses.
The global cardiology information system market size was USD 1.24 billion in 2023, calculated at USD 1.35 billion in 2024 and is expected to reach around USD 3.26 billion by 2034. The market is expanding at a solid CAGR of 9.20% over the forecast period 2024 to 2034. The North America cardiology information system market size reached USD 410 million in 2023. The rising demand for an efficient software platform for the management of cardiovascular diseases management platform is driving the growth of the market.
The global healthcare finance solutions market size was USD 128.04 billion in 2023, calculated at USD 138.05 billion in 2024 and is expected to reach around USD 293.12 billion by 2034, expanding at a CAGR of 7.82% from 2024 to 2034. The North America healthcare finance solutions market size reached USD 51.22 billion in 2023. The continuous need to improve processes and performance and the requirement for hi-tech equipment and technology are some of the factors driving the healthcare finance solutions market growth.
The global clinical documentation improvement market size was USD 4.52 billion in 2023, calculated at USD 4.88 billion in 2024 and is expected to reach around USD 10.44 billion by 2034, expanding at a CAGR of 7.91% from 2024 to 2034. The North America clinical documentation improvement market size reached USD 1.76 billion in 2023. The rising need for mid-RCM (revenue cycle management) services, management of large amounts of healthcare data, and the widespread adoption of standardized documentation protocols have led to the growth of the clinical documentation improvement market.
The global generic pharmaceuticals contract manufacturing market size was USD 72.50 billion in 2023, calculated at USD 76.73 billion in 2024, and is expected to reach around USD 135.36 billion by 2034, expanding at a CAGR of 5.84% from 2024 to 2034. Asia Pacific dominated the generic pharmaceuticals contract manufacturing market with the largest revenue share of 39% in 2023.
The global bioprocess containers market size was USD 2.44 billion in 2023, calculated at USD 3.08 billion in 2024 and is expected to reach around USD 31.09 billion by 2034. The market is expanding at a solid CAGR of 26.03% over the forecast period 2024 to 2034. The North America bioprocess containers market size reached USD 980 million in 2023. The need for bioprocess containers, which are utilized in the manufacture, storage, and transportation of biopharmaceuticals, is driven by an increase in demand.
The global self-monitoring blood glucose devices market size was USD 10.10 billion in 2023, calculated at USD 11.27 billion in 2024 and is expected to reach around USD 33.30 billion by 2034. The market is expanding at a solid CAGR of 11.63% over the forecast period 2024 to 2034. The North America self-monitoring blood glucose devices market size reached USD 3.94 billion in 2023. The rising number of diabetes patients especially type 2 diabetes drives the growth of the self-monitoring blood glucose devices market.
The global fibrate drugs market size was USD 3.25 billion in 2023, calculated at USD 3.42 billion in 2024 and is expected to reach around USD 5.41 billion by 2033, expanding at a CAGR of 5.22% from 2024 to 2033. The global increase in the prevalence and incidence rate of cardiovascular disorders is anticipated to fuel the fibrate drugs market. The North America fibrate drugs market size reached USD 1.27 billion in 2023.
The global biological buffers market size was USD 749.24 million in 2023, calculated at USD 805.73 million in 2024 and is expected to reach around USD 1,549.96 million by 2033, expanding at a CAGR of 7.54% from 2024 to 2033. The biological buffers market has a variety of products, including biological and pharmaceutical buffers, biochemical-grade buffers, and diagnostic-grade buffers, all of which contribute to its growth and vitality.
The global peptide synthesis market size was USD 581.06 million in 2023, calculated at USD 627.72 million in 2024 and is expected to reach around USD 1257.95 million by 2033, expanding at a CAGR of 8.03% from 2024 to 2033. The benefits of peptide synthesis include it helps to design new vaccines, drugs, and enzymes and is also used to prepare enzyme binding sites, epitope-scientific antibodies, and map antibody epitopes. These factors help to the growth of the market. The North America peptide synthesis market size reached USD 214.99 million in 2023.
The global neurology clinical trials market size was USD 5.58 billion in 2023, calculated at USD 5.89 billion in 2024 and is expected to be worth around USD 9.64 billion by 2033, expanding at a CAGR of 5.62% from 2024 to 2033. The benefits of neurology clinical trials include access to the latest therapies, reduced cost, a chance to help others, closer monitoring, and careful and regular monitoring from the research team that includes healthcare professionals, doctors, and others. These factors help to the growth of the market. The North America neurology clinical trials market size reached USD 2.68 billion in 2023.
The global menstrual health apps market size was USD 1.46 billion in 2023, calculated at USD 1.75 billion in 2024 and is expected to reach around USD 9.04 billion by 2033. The market is expanding at a solid CAGR of 20% over the forecast period 2024 to 2033. The rising health awareness among the women, especially in developing countries is expected to fuel the menstrual health apps market’s growth. The North America menstrual health apps market size reached USD 600 million in 2023.
The global epigenetics diagnostics market size was USD 14.68 billion in 2023, calculated at USD 16.90 billion in 2024 and is expected to reach around USD 60.06 billion by 2033. The market is expanding at a solid CAGR of 15.13% over the forecast period 2024 to 2033. The rising prevalence of chronic diseases, an aging population, and the resulting rising investment in the research and development of epigenetics are driving the epigenetics diagnostics market. The North America epigenetics diagnostics market size reached USD 5.73 billion in 2023.
+1 650 460 3308
+91 87933 22019
sales@precedenceresearch.com